These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8061853)
1. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension. Guitard C; Alvisi V; Maibach E; Franck J; Cocco G; Boxho G; Mellein B; Waite R Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853 [TBL] [Abstract][Full Text] [Related]
2. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison. Vreugdenhil G; van Montfrans GA; Jacobs MC; de Bruijn JH; Veerman DP; van Es PN; Mellein B; Guitard C; Thien T; de Leeuw PW Blood Press Suppl; 1994; 2():23-30. PubMed ID: 8061842 [TBL] [Abstract][Full Text] [Related]
3. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension. Fairhurst GJ Blood Press Suppl; 1994; 2():77-80. PubMed ID: 8061852 [TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension. Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848 [TBL] [Abstract][Full Text] [Related]
5. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily. Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845 [TBL] [Abstract][Full Text] [Related]
6. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513 [TBL] [Abstract][Full Text] [Related]
7. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients. de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517 [TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension. Guitard C; Lohmann FW; Alfiero R; Ruina M; Alvisi V Cardiovasc Drugs Ther; 1997 Jul; 11(3):449-57. PubMed ID: 9310273 [TBL] [Abstract][Full Text] [Related]
10. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study]. Widimský J; Lánská V; Hulínský V Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592 [TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study. Hakamäki T; Lehtonen A Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336 [TBL] [Abstract][Full Text] [Related]
12. A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population. Bavanandan S; Morad Z; Ismail O; Chandran A; Thayaparan T; Singaraveloo M Med J Malaysia; 2005 Jun; 60(2):158-62. PubMed ID: 16114156 [TBL] [Abstract][Full Text] [Related]
13. [Spirapril and nitrendipine in arterial hypertension. A comparison of therapeutic effects and tolerance]. Carlsen JE; Galløe A; Leikersfeldt G; Køber L; Winther A; Petersen LN; Lund J; McNair A Ugeskr Laeger; 1990 Oct; 152(42):3076-9. PubMed ID: 2238185 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in the very old. Otterstad JE; Ruilope LM Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension. Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699 [TBL] [Abstract][Full Text] [Related]
16. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial. Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension]. Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888 [TBL] [Abstract][Full Text] [Related]
20. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]